Literature DB >> 2863693

N-myc amplification in malignant astrocytoma.

J A Garson, P G McIntyre, J T Kemshead.   

Abstract

Entities:  

Mesh：

Year:  1985        PMID： 2863693     DOI： 10.1016/s0140-6736(85)92950-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  14 in total

1.  N-myc oncogene amplification in a pediatric case of glioblastoma multiforme.

Authors:  A M Stenger; M L Garrè; A Cama; L Andreussi; M Brisigotti; G P Tonini; P Cornaglia-Ferraris
Journal:  Childs Nerv Syst       Date:  1991-11       Impact factor: 1.475

2.  Phenotypic and genotypic analysis of a human medulloblastoma cell line and transplantable xenograft (D341 Med) demonstrating amplification of c-myc.

Authors:  H S Friedman; P C Burger; S H Bigner; J Q Trojanowski; G M Brodeur; X M He; C J Wikstrand; J Kurtzberg; M E Berens; E C Halperin
Journal:  Am J Pathol       Date:  1988-03       Impact factor: 4.307

3.  Amplification and expression of the N-myc gene in neuroblastoma.

Authors:  C R Bartram; F Berthold
Journal:  Eur J Pediatr       Date:  1987-03       Impact factor: 3.183

4.  Gene amplification is a poor prognostic factor in anaplastic oligodendrogliomas.

Authors:  Ahmed Idbaih; Emmanuelle Crinière; Yannick Marie; Audrey Rousseau; Karima Mokhtari; Michèle Kujas; Younas El Houfi; Catherine Carpentier; Sophie Paris; Blandine Boisselier; Florence Laigle-Donadey; Joëlle Thillet; Marc Sanson; Khê Hoang-Xuan; Jean-Yves Delattre
Journal:  Neuro Oncol       Date:  2008-06-10       Impact factor: 12.300

5.  Loss of heterozygosity in malignant gliomas involves at least three distinct regions on chromosome 10.

Authors:  A E Karlbom; C D James; J Boethius; W K Cavenee; V P Collins; M Nordenskjöld; C Larsson
Journal:  Hum Genet       Date:  1993-09       Impact factor: 4.132

6.  Sustained expression of the human protooncogene MYCN rescues rat embryo cells from senescence.

Authors:  M Schwab; J M Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

7.  Loss of constitutional heterozygosity in chromosome 10 in human glioblastoma.

Authors:  K Watanabe; M Nagai; S Wakai; T Arai; K Kawashima
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

8.  N-Myc-mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer.

Authors:  Adeline Berger; Nicholas J Brady; Rohan Bareja; Brian Robinson; Vincenza Conteduca; Michael A Augello; Loredana Puca; Adnan Ahmed; Etienne Dardenne; Xiaodong Lu; Inah Hwang; Alyssa M Bagadion; Andrea Sboner; Olivier Elemento; Jihye Paik; Jindan Yu; Christopher E Barbieri; Noah Dephoure; Himisha Beltran; David S Rickman
Journal:  J Clin Invest       Date:  2019-07-01       Impact factor: 14.808

9.  MYCN: from oncoprotein to tumor-associated antigen.

Authors:  Vito Pistoia; Fabio Morandi; Annalisa Pezzolo; Lizzia Raffaghello; Ignazia Prigione
Journal:  Front Oncol       Date:  2012-11-16       Impact factor: 6.244

10.  The N-Myc oncoprotein is associated in vivo with the phosphoprotein Max(p20/22) in human neuroblastoma cells.

Authors:  A Wenzel; C Cziepluch; U Hamann; J Schürmann; M Schwab
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.